This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Llerena, A. Articles by de la Rubia, A. Search for Related Content PubMed PubMed Citation Articles by Llerena, A. Articles by de la Rubia, A. Social Bookmarking                   What's this?

QTc Interval, CYP2D6 and CYP2C9 Genotypes and Risperidone Plasma Concentrations

Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Badajoz, Spain, Unit of Research and Clinical Psychopharmacology at Mérida Psychiatric Hospital, Mérida, Spain and University of Beira Interior, Covilhã, Portugal., allerena{at}unex.es

Roland Berecz

Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Badajoz, Spain.

Pedro Dorado

Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Badajoz, Spain and University of Beira Interior, Covilhã, Portugal.

Alfredo de la Rubia

Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Badajoz, Spain and Unit of Research and Clinical Psychopharmacology at Mérida Psychiatric Hospital, Mérida, Spain.

The role of certain drug metabolizing enzymes in cardiotoxicity, such as CYP2D6 for thioridazine, has been suggested. Risperidone has been shown to inhibit the delayed rectifier leading to lengthening of cardiac repolarization. The heart-rate corrected QT (QTc) interval lengthening has been reported in psychiatric patients receiving risperidone under steady-state conditions. CYP2D6 is involved in the metabolism of risperidone to 9-hydroxy (OH)-risperidone. CYP2C9 enzyme is also involved in the metabolism of several psychotropic drugs, although there are no data about its implication in risperidone metabolism. The present study aimed to evaluate the influence of CYP2D6 and CYP2C9 genotypes, and plasma concentrations of risperidone and 9-OH-risperidone on the QTc interval in patients under steady-state conditions. The relevance of CYP2D6 and CYP2C9 genotypes on risperidone metabolism was also analysed. Thirty-five White European psychiatric patients receiving risperidone monotherapy were studied. QTc interval was longer (p < 0.05) in subjects with one active CYP2D6 gene compared to those with two. The number of CYP2D6 active genes was related to the dose-corrected plasma concentration of risperidone (p < 0.05), the active moiety (risperidone plus 9-OH-risperidone) (p < 0.05) and the risperidone/9-OH-risperidone ratio (p < 0.05). CYP2C9genotypes were not related to plasma concentrations of risperidone or 9-OH-risperidone, nor QTc interval. The results suggest that CYP2D6, but not CYP2C9, may be related to QTc lengthening during treatment with risperidone. The effect of the CYP2D6 genotype in risperidone metabolism is also shown.

Key Words: CYP2D6 • CYP2C9 • 9-hydroxy-risperidone • QTc • risperidone

Journal of Psychopharmacology, Vol. 18, No. 2, 189-193 (2004)
DOI: 10.1177/0269881104042618


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?